An Ayurvedic Approach in the Management of Ashmari (Urolithiasis)
Keywords:
Ashmari, Urolithiasis, AshtamahagadaAbstract
In ancient centuries urolithiasis was often a disease, with a catastrophic outcome all too often leading to the patient’s death. Even today, urolithiasis is the one of the most common affliction of the urinary tract. Detailed medical literature on urolithiasis is available from ancient India. As per classics, Ashmari is included in Ashtamahagada due to its fatal nature. Description of Ashmari is found in almost all Samhita of Ayurveda as etiopathogenesis, classification, symptomatology, complications and management in a most scientific manner. Modern science also emphasizes on involvement of various factors like heredity, age, sex, metabolic disorders, hydration status, mineral content of water, nutritional deficiency, etc. For urinary stone formation. Urolithiasis typically occurs in middle age which is the most productive years of life. It causes pain, loss of working time, medical expenses, needs for hospitalization as well as it is infrequent cause of renal failure and death. Different management of urolithiasis has been developed in modern system but inspite of all these techniques, surgery remain treatment of choice. Even after surgery patients have to take medicines to check its further recurrence. In this way the need of medicinal treatment is always required.
Downloads
References
Barros, M.E., Lima, R., Mercuri, L.P., Matos, J.R., Schor, N. and Boim, M.A. 2006. Effect of extract of Phyllanthus niruri on crystal deposition in experimental urolithiasis. Urological Research, 34(6): 351-357.
Patwardhan, B., Warude, D., Pushpangadan, P. and Bhatt, N. 2005. Ayurveda and traditional Chinese medicine: a comparative overview. Evidence-Based Complementary and Alternative Medicine, 2(4): 465-473.
Patwardhan, B.D. and Vaidya, A.D. 2010. Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches. Indian Journal of Experimental Biology, 48(3): 220-227.
Deshpande, A.P., Jawalgekar, R.R. and Ranade, S. 2007. Chapter 7, Dravyagunvigyan, Part vols. 1 and 2, Anmol Prakashan, 355-356 pp.
Deshpande, A.P., Jawalgekar, R.R. and Ranade, S. 2007. Chapter 17, Dravyagunvigyan, Part vols. 1 and 2, Anmol Prakashan, 616-618 pp.
Deshpande, A.P., Jawalgekar, R.R. and Ranade, S. 2007. Chapter 337, Dravyagunvigyan, Part vols. 1 and 2, Anmol Prakashan, 971-972 pp.
Ganga Sahay Pandey. 2006. Bhavprakashnighantu. Chaumkhamba Bharti Academy, 641-642 pp.
Pak, C.Y. 1998. Kidney stones. Lancet, 351(9118): 1797-1801.
Patankar, S., Dobhada, S., Bhansali, M., Khaladkar, S. and Modi, J. 2008. A prospective, randomized, controlled study to evaluate the efficacy and tolerability of Ayurvedic formulation “varuna and banana stem” in the management of urinary stones. The Journal of Alternative and Complementary Medicine, 14(10): 1287-1290.
Patankar, S. and Mujumdar, A. 2014. Acute and Sub-Acute Safety studies of Herbmed plus-a Herbal formulation in laboratory animal. International Journal of Pharmacy and Pharmaceutical Sciences, 6(11): 288-291.
Francis, Jones, K.K. 2003. Prevalence of kidney stones. American Journal of Public Medicine, 62: 54-58.
Uribarri, J., Oh, M.S. and Carroll, H.J. 1989. The first kidney stone. Annals of Internal Medicine, 111(12): 1006-1009.
Glowacki, L.S., Beecroft, M.L., Cook, R.J., Pahl, D. and Churchill, D.N. 1992. The natural history of asymptomatic urolithiasis. The Journal of Urology, 147(2): 319-321.
Burgher, A., Beman, M., Holtzman, J.L. and Monga, M. 2004. Progression of nephrolithiasis: long-term outcomes with observation of asymptomatic calculi. Journal of Endourology, 18(6): 534-539.
Hübner, W. and Porpaczy, P. 1990. Treatment of caliceal calculi. British Journal of Urology, 66(1): 9-11.
Collins, J.W. and Keeley Jr, F.X. 2002. Is there a role for prophylactic shock wave lithotripsy for asymptomatic calyceal stones?. Current Opinion in Urology, 12(4): 281-286.
Baskar, R., Malini, M.M., Varalakshmi, P., Balakrishna, K. and Bhimarao, R. 1996. Effect of Lupeol isolated from C. nurvala stem bark against free radical induced toxicity in experimental urolithiasis. Fitoterapia, 67(2): 121-125.
Pak, C.Y. 1989. Prevention and treatment of kidney stones. Role of medical preventionJournal of Urology, 141(3 Pt 2): 798-801
Bashir, S., Gilani, A.H., Siddiqui, A.A., Pervez, S., Khan, S.R., Sarfaraz, N.J. and Shah, A.J. 2010. Berberis vulgaris root bark extract prevents hyperoxaluria induced urolithiasis in rats. Phytotherapy Research, 24(8): 1250-1255.
Ettinger, B., Pak, C.Y., Citron, J.T., Thomas, C., Adams-Huet, B. and Vangessel, A. 1997. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. The Journal of Urology, 158(6): 2069-2073.
Pandit Durgadutt Shastri. 2002. Sharangdhar samhita Chapter 12. ChaukhambaVidyabhavan, 465-512 pp.
Pak, C.Y., Fuller, C., Sakhaee, K., Preminger, G.M. and Britton, F. 1985. Long-term treatment of calcium nephrolithiasis with potassium citrate. The Journal of Urology, 134(1): 11-19.
Sridharan, K. and Sivaramakrishnan, G. 2017. Medical expulsive therapy in urolithiasis: a mixed treatment comparison network meta-analysis of randomized controlled clinical trials. Expert Opinion on Pharmacotherapy, 18(14): 1421-1431.
Varalakshmi, P., Latha, E., Shamila, Y. and Jayanthi, S. 1991. Effect of Crataeva nurvala on the biochemistry of the small intestinal tract of normal and stone-forming rats. Journal of Ethnopharmacology, 31(1): 67-73.
Aggarwal, A., Tandon, S., Singla, S.K. and Tandon, C. 2010. Reduction of oxalate-induced renal tubular epithelial (NRK-52E) cell injury and inhibition of calcium oxalate crystallisation in vitro by aqueous extract of Achyranthes aspera. International Journal of Green Pharmacy, 4(3): 159-164.
Agarwal, A., Singla, S.K., Gandhi, M. and Tandon, C. 2012. Preventive and curative effects of A. aspera Linn extract in experimentally induced nephrolithiasis. Indian Journal of Experimental Biology, 50: 201-208.
Pareta, S.K., Patra, K.C. and Harwansh, R.K. 2011. In-vitro calcium oxalate crystallization inhibition by A. Indica Linn Hydroalcoholic extract. An approach to antilithiasis. International Journal of Pharma and Biosciences, 2(1): 432-43
Shah, J.G., Patel, B.G., Patel, S.B. and Patel, R. 2012. Effect of Hordeum vulgare Linn. seeds on glycolic acid induced urolithiasis in rats. Pharmacognosy Communications, 2(2): 34-39.
Basavaraj, D.R., Biyani, C.S., Browning, A.J. and Cartledge, J.J. 2007. The role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones. EAU-EBU Update Series, 5(3): 126-136.
Varalakshmi, P., Shamila, Y. and Latha, E. 1990. Effect of Crataeva nurvala in experimental urolithiasis. Journal of Ethnopharmacology, 28(3): 313-321.
Prasobh, G.R. and Revikumar, K.G. 2012. Effect of MUSA tablet on ethylene glycol-induced urolithiasis in rats. International Journal of Research in Pharmaceutical and Biomedical Sciences, 3(3): 1251-1255.
Kailash, P. and Varalakshmi, P. 1992. Effect of banana stem juice on biochemical changes in liver of normal and hyperoxaluric rats. Indian Journal of Experimental Biology, 30(5): 440-442.
Published
How to Cite
Issue
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.